Mini reviewPublished 29 Mar 2024
Advancements in Pharmacology for Preterm Birth Prevention: A Promising Frontier in Maternal-Fetal Medicine
Department of Pharmacology, University of Florida, U.S.A
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Preterm birth remains a significant challenge in maternal-fetal medicine, posing risks to both maternal and neonatal health. Pharmacological interventions have emerged as promising strategies for preterm birth prevention, offering a range of options to prolong gestation and improve neonatal outcomes. This abstract explores recent advancements in pharmacology for preterm birth prevention, including progesterone supplementation, cervical ripening agents, antenatal corticosteroids, and antibiotics for Preterm Premature Rupture of Membranes (PPROM). Recent research efforts have focused on identifying novel pharmacological targets and personalized approaches, driven by advancements in pharmacogenomics. Despite challenges such as optimizing dosing regimens and addressing side effects, pharmacology represents a promising frontier in maternal-fetal medicine, offering hope for reducing the global burden of preterm birth and improving outcomes for mothers and newborns alike.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalWorld Journal of Pharmacology and Toxicology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Alex Kate”